Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Active not recruiting × Tislelizumab × Gastrointestinal × Clear all

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Colorectal Neoplasms 277 Pancreatic Neoplasms 195 Stomach Neoplasms 145 Carcinoma, Hepatocellular 140 Colonic Neoplasms 107 Rectal Neoplasms 92 Carcinoma, Non-Small-Cell Lung 83 Esophageal Neoplasms 76 Neoplasms 62 Breast Neoplasms 62 Liver Neoplasms 58 Ovarian Neoplasms 53 Melanoma 46 Cholangiocarcinoma 43 Neoplasm Metastasis 42 Lung Neoplasms 42 Gastrointestinal Neoplasms 36 Esophageal Squamous Cell Carcinoma 35 Squamous Cell Carcinoma of Head and Neck 33 Sarcoma 30 Carcinoma, Renal Cell 29 Prostatic Neoplasms 27 Anus Neoplasms 27 Biliary Tract Neoplasms 24 Uterine Cervical Neoplasms 22 Endometrial Neoplasms 22 Head and Neck Neoplasms 21 Triple Negative Breast Neoplasms 17 Gallbladder Neoplasms 16 Adenocarcinoma Of Esophagus 16

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04906044 2023-11-18

STARS-RC03

The First Hospital of Jilin University

Phase 1 Active not recruiting

Gastrointestinal

Tislelizumab

Data powered by HemOnc (CC BY 4.0) Colophon ⚡